A STUDY OF CLINICAL SPECTRUM, RISK FACTORS AND OUTCOME OF DRUG-INDUCED MOVEMENT DISORDERS
Objective: We aimed to characterize the spectrum of DIMDs, and the culprit agents commonly encountered in the movement disorder clinic. We also set out to…Video-guided Optimization of Stimulation Settings in Patients with Parkinson’s Disease and Deep Brain Stimulation
Objective: To investigate whether video-based evaluations of motor control and changes of predefined stimulation parameters via patient programmer can improve motor status in Parkinson’s disease…Correlation between 3 Tesla Brain MRI Nigrosome-1 imaging and SPECT 123I-Ioflupane in parkinsonian disorders
Objective: To correlate nigrosome-1 (NG1) imaging and SPECT 123I-Ioflopane findings to determine the feasibility and diagnostic value of NG1 imaging in a real-world clinical setting.…Impact on non-motor symptoms, cognition, and QoL after 1-year of DBS for Parkinson’s Disease: An interim report from the ADROIT NAPA sub-study
Objective: To present the impact on cognition, quality of life, and non-motor symptoms after 1-year of DBS for Parkinson’s Disease through the ADROIT post-market study.…Edentulous stereotypy: Common lacunae in the identification of an old malady
Objective: To characterize the common errors or pitfalls in the recognition of edentulous stereotypy Background: Edentulous stereotypy is a well-characterized abnormal movement of the jaw…Closing the gap: Increasing access to genetic testing and counseling for Hispanics through PD research
Objective: To report preliminary genetic findings of Hispanic participants from the PD GENEration Registry and GEN-EP Latino study. Background: The incidence of Parkinson disease across…GP2: Growing a research community in the Parkinson’s disease genetics field through training and networking
Objective: To establish a virtual ‘center of excellence’ with resources and expertise to serve the training needs of the Global Parkinson’s Genetics Program (GP2; www.gp2.org)…Temporal dynamics and longitudinal predictors of apathy in Parkinson’s disease
Objective: To determine how apathy varies across different disease stages of Parkinson’s disease (PD) and the longitudinal predictors of its development, using a large PD…Goals for Improvement in Essential Tremor Patients Following Focused Ultrasound VIM Thalamotomy
Objective: To report the most common expectations prior to focused ultrasound (FUS) treatment in essential tremor (ET) patients using the Goal Attainment Scaling method (GAS).…Safety and Tolerability of Apomorphine Sublingual Film and Subcutaneous Apomorphine for the Treatment of OFF Episodes in Parkinson’s Disease
Objective: Evaluate safety and tolerability of apomorphine sublingual film (SL-APO) vs subcutaneous apomorphine (SC-APO) for the treatment of OFF episodes in patients with Parkinson’s disease…
- « Previous Page
- 1
- …
- 582
- 583
- 584
- 585
- 586
- …
- 1734
- Next Page »